Records containing: Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-02-07Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Flexible 19G Endobronchial Ultrasound Transbronchial Needle (Flex 19G EBUS-TBNA) in the Assessment of Mediastinal and Hilar Lymph-adenopathy: a Randomised Trial
-
CLINICAL_TRIALS study record update · 2017-01-31Palliative Care Interventions for Outpatients With Newly Diagnosed Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-31A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-31Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-27Evaluation of the Archimedes™ System for Transparenchymal Nodule Access
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-01-27Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients Who Are Not Candidates for Lobectomy or Patients With High Risk of Local Recurrence
-
CLINICAL_TRIALS study record update · 2017-01-25A Phase II First-Line Study of a Combination of Pemetrexed, Carboplatin and Bevacizumab in Advanced Nonsquamous NSCLC Evaluating Efficacy and Tolerability in Elderly Patients (Age ≥ 70 Yrs) With Good Performance Status (PS < 2)
-
CLINICAL_TRIALS study record update · 2017-01-24A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-23Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial
-
CLINICAL_TRIALS study record update · 2017-01-20High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection
-
CLINICAL_TRIALS study record update · 2017-01-20A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-19A Phase II Study of Taxotere and Gemcitabine for Stages III-B and IV Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-19A Phase I/II Study of Hypofractionated Stereotactic Body Radiotherapy for Stage I/II Non-small Cell Lung Cancer Within the Central Lung Region and the Prognostic Impact of FDG Positron Emission Tomography
-
CLINICAL_TRIALS study record update · 2017-01-10Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
-
CLINICAL_TRIALS study record update · 2017-01-06ClinicalTrials.gov study NCT01887769
-
CLINICAL_TRIALS study record update · 2017-01-06Feasibility of an Eight-week Telerehabilitation Program for Patients With Unresectable Thoracic Neoplasia Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2017-01-06Comparison of Gene Mutations Among the Primary Tumor, Matched Metastatic Lymph Node and Peripheral Blood in Advanced Nonsquamous Non-small Cell Lung Cancer Using Next-generation Sequencing
-
CLINICAL_TRIALS study record update · 2017-01-06The Clinical Study of Electromagnetic Navigation Bronchoscopy (ENB) Guided Radiofrequency Ablation (RFA) for the Treatment of Early-stage Peripheral Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-01-04A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Performance Status 2 (PS-2)
-
CLINICAL_TRIALS study record update · 2016-12-23A Randomized Phase III Study of Sublobar Resection Versus Sublobar Resection Plus Brachytherapy in High Risk Patients With Non-Small Cell Lung Cancer (NSCLC), 3cm or Smaller
-
CLINICAL_TRIALS study record update · 2016-12-22A Phase II Trial of the Combination of OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (ADENOBAC)
-
CLINICAL_TRIALS study record update · 2016-12-19Important Non-technical Skills When Performing Video-assisted Thoracoscopic Surgery: Perceptions of the Operating Team
-
CLINICAL_TRIALS study record update · 2016-12-15Phase II Study of Oxaliplatin in Combination With Gemcitabine for 2 Line Treatment of NSCLC Patients With Advanced and Metastatic Disease
-
CLINICAL_TRIALS study record update · 2016-12-15Carboplatin and Irinotecan Concomitantly With Radiation Therapy Followed by Consolidation Chemotherapy With Docetaxel for Locally Advanced Non-Small Cell Lung Cancer (GIA 12177).
-
CLINICAL_TRIALS study record update · 2016-12-15Novel Tumor Vaccine gp96-Ig Fusion Protein in Advanced (Stage IIIB), Relapsed or Metastatic (Stage IV) Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Failed First Line Chemotherapy